nodes	percent_of_prediction	percent_of_DWPC	metapath
Metocurine—CHRND—Highly sodium permeable acetylcholine nicotinic receptors—CHRNA4—attention deficit hyperactivity disorder	0.0623	0.073	CbGpPWpGaD
Metocurine—CHRNA1—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0434	0.0508	CbGpPWpGaD
Metocurine—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0412	0.0482	CbGpPWpGaD
Metocurine—CHRND—Presynaptic nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0405	0.0474	CbGpPWpGaD
Metocurine—CHRNA1—Effects of Botulinum toxin—SNAP25—attention deficit hyperactivity disorder	0.0403	0.0472	CbGpPWpGaD
Metocurine—CHRNA1—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0369	0.0432	CbGpPWpGaD
Metocurine—CHRND—Acetylcholine Binding And Downstream Events—CHRNA4—attention deficit hyperactivity disorder	0.0358	0.0419	CbGpPWpGaD
Metocurine—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0351	0.0411	CbGpPWpGaD
Metocurine—CHRNA1—Presynaptic nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0344	0.0403	CbGpPWpGaD
Metocurine—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0327	0.0383	CbGpPWpGaD
Metocurine—CHRNA1—Acetylcholine Binding And Downstream Events—CHRNA4—attention deficit hyperactivity disorder	0.0304	0.0357	CbGpPWpGaD
Metocurine—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNA4—attention deficit hyperactivity disorder	0.0289	0.0339	CbGpPWpGaD
Metocurine—CHRND—cardiovascular system—attention deficit hyperactivity disorder	0.0218	0.149	CbGeAlD
Metocurine—CHRNA2—forebrain—attention deficit hyperactivity disorder	0.0179	0.122	CbGeAlD
Metocurine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.0129	0.0151	CbGpPWpGaD
Metocurine—CHRNB1—midbrain—attention deficit hyperactivity disorder	0.011	0.0752	CbGeAlD
Metocurine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.011	0.0128	CbGpPWpGaD
Metocurine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.0107	0.073	CbGeAlD
Metocurine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.0104	0.0122	CbGpPWpGaD
Metocurine—CHRM2—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0103	0.0121	CbGpPWpGaD
Metocurine—CHRM2—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0101	0.0118	CbGpPWpGaD
Metocurine—CHRNA2—nervous system—attention deficit hyperactivity disorder	0.0097	0.0664	CbGeAlD
Metocurine—CHRND—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00969	0.0113	CbGpPWpGaD
Metocurine—CHRNA2—central nervous system—attention deficit hyperactivity disorder	0.00934	0.064	CbGeAlD
Metocurine—CHRNA2—cerebellum—attention deficit hyperactivity disorder	0.00913	0.0625	CbGeAlD
Metocurine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00901	0.0617	CbGeAlD
Metocurine—CHRNA1—brain—attention deficit hyperactivity disorder	0.00893	0.0612	CbGeAlD
Metocurine—CHRM2—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.00867	0.0102	CbGpPWpGaD
Metocurine—CHRM2—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.00849	0.00994	CbGpPWpGaD
Metocurine—CHRNB1—cerebellum—attention deficit hyperactivity disorder	0.00849	0.0582	CbGeAlD
Metocurine—CHRNA1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00824	0.00965	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00783	0.00917	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00743	0.0087	CbGpPWpGaD
Metocurine—CHRNA2—brain—attention deficit hyperactivity disorder	0.00741	0.0508	CbGeAlD
Metocurine—CHRNB1—brain—attention deficit hyperactivity disorder	0.0069	0.0473	CbGeAlD
Metocurine—CHRNA1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00631	0.00739	CbGpPWpGaD
Metocurine—CHRM2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.00612	0.00717	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.006	0.00702	CbGpPWpGaD
Metocurine—CHRM2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.00589	0.00689	CbGpPWpGaD
Metocurine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00578	0.0396	CbGeAlD
Metocurine—CHRM2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.00569	0.00666	CbGpPWpGaD
Metocurine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00568	0.00665	CbGpPWpGaD
Metocurine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00557	0.0381	CbGeAlD
Metocurine—CHRM2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.00551	0.00645	CbGpPWpGaD
Metocurine—CHRM2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00542	0.00634	CbGpPWpGaD
Metocurine—CHRM2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00535	0.00626	CbGpPWpGaD
Metocurine—CHRM2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00515	0.00602	CbGpPWpGaD
Metocurine—CHRM2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00498	0.00584	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00496	0.00581	CbGpPWpGaD
Metocurine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00483	0.00565	CbGpPWpGaD
Metocurine—CHRM2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00478	0.0056	CbGpPWpGaD
Metocurine—CHRM2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00463	0.00542	CbGpPWpGaD
Metocurine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00458	0.00537	CbGpPWpGaD
Metocurine—CHRM2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00455	0.00533	CbGpPWpGaD
Metocurine—CHRM2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0045	0.00527	CbGpPWpGaD
Metocurine—CHRM2—brain—attention deficit hyperactivity disorder	0.00442	0.0303	CbGeAlD
Metocurine—CHRND—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00427	0.005	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00422	0.00494	CbGpPWpGaD
Metocurine—CHRM2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00419	0.00491	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00401	0.00469	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00397	0.00464	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.0038	0.00445	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00363	0.00425	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00354	0.00414	CbGpPWpGaD
Metocurine—CHRM2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00349	0.00409	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00345	0.00404	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00337	0.00395	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00327	0.00383	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00323	0.00378	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.0032	0.00375	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.0032	0.00374	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00307	0.0036	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00304	0.00356	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00301	0.00352	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00301	0.00352	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00298	0.00349	CbGpPWpGaD
Metocurine—CHRM2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00293	0.00344	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00286	0.00334	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00278	0.00325	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00271	0.00317	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00264	0.00309	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00258	0.00303	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00256	0.00299	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00254	0.00297	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00245	0.00287	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00245	0.00287	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00243	0.00284	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00241	0.00282	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00238	0.00278	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.0023	0.0027	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—COMT—attention deficit hyperactivity disorder	0.0023	0.0027	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00229	0.00268	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00219	0.00256	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00214	0.00251	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00205	0.00241	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00199	0.00233	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00196	0.00229	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00195	0.00228	CbGpPWpGaD
Metocurine—CHRM2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00195	0.00228	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00194	0.00228	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00194	0.00227	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00186	0.00218	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00185	0.00216	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00177	0.00207	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00171	0.002	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00167	0.00196	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00164	0.00192	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00164	0.00192	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00155	0.00182	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00146	0.00171	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00135	0.00158	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.0013	0.00152	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00127	0.00149	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00127	0.00149	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00124	0.00145	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00119	0.0014	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00118	0.00138	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00116	0.00136	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00115	0.00134	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00113	0.00132	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00111	0.0013	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0011	0.00129	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00109	0.00128	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00106	0.00125	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00105	0.00122	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00104	0.00121	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00103	0.00121	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00101	0.00119	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00101	0.00118	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000993	0.00116	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000962	0.00113	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000941	0.0011	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000911	0.00107	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000896	0.00105	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000885	0.00104	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000882	0.00103	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000824	0.000965	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000771	0.000902	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000734	0.000859	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000719	0.000842	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000717	0.000839	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000694	0.000813	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000682	0.000799	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000674	0.000789	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000674	0.000789	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000666	0.00078	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000653	0.000764	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000628	0.000735	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000587	0.000687	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000577	0.000676	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000534	0.000625	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000498	0.000583	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000458	0.000536	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000452	0.00053	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00044	0.000515	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000436	0.00051	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000405	0.000474	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000396	0.000463	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000394	0.000461	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000392	0.000459	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000386	0.000452	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000385	0.000451	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000381	0.000446	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000378	0.000443	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000368	0.000431	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000356	0.000417	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000355	0.000415	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00035	0.00041	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000346	0.000405	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000322	0.000377	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000267	0.000313	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000248	0.000291	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000234	0.000274	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000226	0.000264	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000217	0.000254	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00021	0.000246	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000207	0.000242	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000204	0.000239	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00019	0.000223	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000133	0.000156	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.06e-05	8.27e-05	CbGpPWpGaD
